Share Share on Facebook Share on Twitter Pinterest Email Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com 0 Related Posts Skyharbour Closes $2.1 Million Private Placement of Flow-Through Shares December 6, 2025 Tech Weekly: S&P 500 Closes Near Record Ahead of Fed Interest Rate Decision December 6, 2025 Nevada Sunrise Clarifies Investor Relations Agreement December 6, 2025